American Healthcare REIT (AHR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Achieved a transformational Q3 2024 with strong operational and financial performance, highlighted by the full buyout of Trilogy for $258 million, major acquisitions in SHOP and ISHC, and a portfolio of 324 properties across four main segments with occupancy rates between 85% and 100%.
Completed two major public equity offerings in 2024, raising over $1.24 billion, including $471.2 million in a follow-on offering, with proceeds used to fund acquisitions, repay debt, and acquire noncontrolling interests.
Portfolio positioned for sustainable growth, with robust demand in senior housing and care, and a focus on leveraging Trilogy's best practices across the platform.
Portfolio expanded through acquisitions of senior housing properties and land for future development, while also disposing of select assets.
Net loss attributable to controlling interest was $4.1 million for Q3 2024, with normalized FFO per share at $0.36.
Financial highlights
Q3 2024 revenues were $523.8 million, up from $464.2 million in Q3 2023; NAREIT FFO attributable to controlling interest was $35.6 million, normalized FFO was $47.7 million, and NFFO per diluted share was $0.36.
Adjusted EBITDA for Q3 2024 was $87.0 million; net loss was $3.1 million.
Q3 2024 Cash NOI was $100.5 million, up from $84.8 million in Q3 2023; total portfolio Same-Store NOI grew 17% year-over-year, led by SHOP (61.8%) and ISHC (22.6%).
Cash flows from operations for the nine months ended September 30, 2024 were $116.6 million, up from $72.8 million in the prior year period.
Declared a $0.25 per share cash distribution for Q3 2024.
Outlook and guidance
Increased full-year 2024 NFFO guidance to $1.40–$1.43 per share and NAREIT FFO per share guidance to $1.28–$1.31.
Raised total portfolio Same-Store NOI growth guidance to 15.0%–17.0% for 2024; ISHC: 21.0%–23.0%, SHOP: 51.5%–53.5%, Outpatient Medical: (0.5)%–0.0%, Triple-Net: 2.0%–4.0%.
Management expects continued inflationary pressures on labor and operating costs, but aims to offset these through higher rent and care fee increases.
Quarterly cash distributions of $0.25 per share are expected to continue, subject to board approval and available funds.
Latest events from American Healthcare REIT
- Strong demand, limited supply, and integrated care drive robust growth and operational alignment.AHR
Citi’s Miami Global Property CEO Conference 20264 Mar 2026 - Double-digit NOI growth and strong occupancy highlight robust performance and future growth potential.AHR
Investor presentation2 Mar 2026 - Double-digit NOI and NFFO growth in 2025, with strong 2026 guidance and major acquisitions.AHR
Q4 202527 Feb 2026 - Strong Q2 results, raised 2024 guidance, and improved leverage driven by SHOP and ISHC growth.AHR
Q2 20242 Feb 2026 - Strong organic growth and disciplined capital allocation drive value, led by the Trilogy platform.AHR
Nareit REIT Week: 2024 Investor Conference31 Jan 2026 - Strong multi-year growth driven by managed care, Trilogy synergies, and portfolio optimization.AHR
Citi’s 30th Annual Global Property CEO Conference 202523 Dec 2025 - Double-digit NOI and FFO growth in 2024, with strong 2025 guidance and improved leverage.AHR
Q4 202417 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and new equity plan amid strong 2024 results.AHR
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, auditor, compensation, and new stock purchase plan.AHR
Proxy Filing2 Dec 2025